LORETTA SMITHSON: Open Payments
NPI 1548927619 · MANSFIELD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$902 in 21 payments from 8 companies in 2025. Trend: 2023 $293 · 2024 $422 · 2025 $902
Food & beverage: $902
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $285 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $156 |
| SANOFI-AVENTIS U.S. LLC | 1 | $125 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $103 |
| Alkermes, Inc. | 1 | $97 |
| Novo Nordisk Inc | 1 | $87 |
| Exact Sciences Corporation | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: VRAYLAR, CAPLYTA, TZIELD, LYBALVI, Wegovy, Cologuard Collection Kit, Auvelity.
Industry payments across AR — which companies pay providers there.
